The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Measurement of spatial and antibody-based PD-L1 heterogeneity in non-small cell lung cancer.
 
Patricia Gaule
No Relationships to Disclose
 
Jamaal Rehman
No Relationships to Disclose
 
James William Smithy
No Relationships to Disclose
 
Maria Toki
No Relationships to Disclose
 
Gang Han
No Relationships to Disclose
 
Veronique Neumeister
Consulting or Advisory Role - Mitsubishi Tanabe Pharma (I)
 
Daniel E. Carvajal-Hausdorf
No Relationships to Disclose
 
Kurt Alex Schalper
No Relationships to Disclose
 
Vasiliki Pelekanou
No Relationships to Disclose
 
Brad Wasserman
No Relationships to Disclose
 
Roy S. Herbst
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; NovaRX; pfizer
Consulting or Advisory Role - Biothera; DiaTech Oncology; Endocyte; Kolltan Pharmaceuticals; N-of-One
Research Funding - Genentech/Roche
 
David L. Rimm
Leadership - MDAgree
Stock and Other Ownership Interests - Metamark Genetics
Honoraria - ACD Pharmaceuticals; Amgen; AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - Biocept; Cernostics; Genoptix; Perkin Elmer
Research Funding - Cepheid; Gilead Sciences; Kolltan Pharmaceuticals; OncoPlex Diagnostics; Perkin Elmer
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Travel, Accommodations, Expenses - Ventana Medical Systems